Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1978 1
1979 2
1982 1
1983 3
1984 2
1986 2
1988 1
1989 3
1990 1
1991 2
1992 4
1993 5
1994 2
1995 5
1996 5
1997 5
1998 7
1999 7
2000 5
2001 6
2002 8
2003 8
2004 10
2005 7
2006 12
2007 14
2008 8
2009 17
2010 28
2011 17
2012 16
2013 21
2014 18
2015 40
2016 32
2017 29
2018 31
2019 42
2020 183
2021 298
2022 223
2023 138
2024 57

Text availability

Article attribute

Article type

Publication date

Search Results

1,129 results

Results by year

Filters applied: . Clear all
Page 1
Olfaction in COPD.
Thorstensen WM, Oie MR, Dahlslett SB, Sue-Chu M, Steinsvag SK, Helvik AS. Thorstensen WM, et al. Rhinology. 2022 Feb 1;60(1):47-55. doi: 10.4193/Rhin21.037. Rhinology. 2022. PMID: 34647543
The T score was not significantly different between the two groups. Hyposmia and anosmia were present in up to 79% of patients with COPD. ...COPD, higher age, male sex and allergy were associated with a lower TDI score, while CRSsNP was not associated with th …
The T score was not significantly different between the two groups. Hyposmia and anosmia were present in up to 79% of patients …
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps.
Mullol J, Bachert C, Amin N, Desrosiers M, Hellings PW, Han JK, Jankowski R, Vodicka J, Gevaert P, Daizadeh N, Khan AH, Kamat S, Patel N, Graham NMH, Ruddy M, Staudinger H, Mannent LP. Mullol J, et al. J Allergy Clin Immunol Pract. 2022 Apr;10(4):1086-1095.e5. doi: 10.1016/j.jaip.2021.09.037. Epub 2021 Oct 7. J Allergy Clin Immunol Pract. 2022. PMID: 34628065 Free article. Clinical Trial.
METHODS: In the randomized SINUS-24 and SINUS-52 studies, adults with severe CRSwNP received dupilumab 300 mg subcutaneously or matching placebo every 2 weeks for 24 or 52 weeks, respectively. Smell was assessed using daily patient-reported LoS score (0-3) and University o …
METHODS: In the randomized SINUS-24 and SINUS-52 studies, adults with severe CRSwNP received dupilumab 300 mg subcutaneously or matching pla …
Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
Yan CH, Jang SS, Lin HC, Ma Y, Khanwalkar AR, Thai A, Patel ZM. Yan CH, et al. Int Forum Allergy Rhinol. 2023 Jun;13(6):989-997. doi: 10.1002/alr.23116. Epub 2022 Dec 21. Int Forum Allergy Rhinol. 2023. PMID: 36507615 Free PMC article. Clinical Trial.
Patients were randomized to three intranasal injections of either PRP or sterile saline into their olfactory clefts. The primary outcome measure was change in Sniffin' Sticks score (threshold, discrimination, and identification [TDI]) from baseline. The secondary end point …
Patients were randomized to three intranasal injections of either PRP or sterile saline into their olfactory clefts. The primary outcome mea …
Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.
Pallanti S. Pallanti S. Compr Psychiatry. 2020 Jul;100:152184. doi: 10.1016/j.comppsych.2020.152184. Epub 2020 May 11. Compr Psychiatry. 2020. PMID: 32422426 Free PMC article. Review.
Anosmia and hypogeusia, the inability or decreased ability to smell and taste, have been reported as common complaints in SARS-CoV-2 patients who were still in an asymptomatic phase. ...The British Association of Otorhinolaryngology (ENT-UK) considers loss of sense of smel …
Anosmia and hypogeusia, the inability or decreased ability to smell and taste, have been reported as common complaints in SARS-CoV-2 …
Olfactory Fluctuation Revisited.
Hsieh JW, Daskalou D, Detroux V, Sipione R, Senn P, Hugentobler M, Landis BN. Hsieh JW, et al. Laryngoscope. 2020 Oct;130(10):2442-2447. doi: 10.1002/lary.28918. Epub 2020 Aug 1. Laryngoscope. 2020. PMID: 32738075

RESULTS: OF was more prevalent in sinonasal disease (42.4%) compared to other putative etiologies of olfactory dysfunction such as postinfectious (28%) or posttraumatic (11.7%) (X2 [5, n = 440] = 24.98; P < .0001). OF was strongly associated with Sniffin' Sticks score c

…
RESULTS: OF was more prevalent in sinonasal disease (42.4%) compared to other putative etiologies of olfactory dysfunction such as postinfec …
Olfactory and taste dysfunctions in COVID-19.
Rouadi PW, Idriss SA, Bousquet J. Rouadi PW, et al. Curr Opin Allergy Clin Immunol. 2021 Jun 1;21(3):229-244. doi: 10.1097/ACI.0000000000000735. Curr Opin Allergy Clin Immunol. 2021. PMID: 33560742 Review.
RECENT FINDINGS: We reviewed the literature on OD and TD during the COVID-19 pandemic analyzing current data on pathogenesis and clinical correlates including prevalence, recovery rates, risk factors, and predictive power. Also, we evaluated various methods of subjective a …
RECENT FINDINGS: We reviewed the literature on OD and TD during the COVID-19 pandemic analyzing current data on pathogenesis and clinical co …
HDAC Inhibition as Neuroprotection in COVID-19 Infection.
Sixto-López Y, Correa-Basurto J. Sixto-López Y, et al. Curr Top Med Chem. 2022;22(16):1369-1378. doi: 10.2174/1568026622666220303113445. Curr Top Med Chem. 2022. PMID: 35240959 Review.
COVID-19 shows various clinical symptoms (fever, cough, fatigue, diarrhea, body aches, headaches, anosmia, and hyposmia). Approximately 30% of patients with COVID-19 showed neurological symptoms, from mild to severe manifestations including headache, dizziness, impaired co …
COVID-19 shows various clinical symptoms (fever, cough, fatigue, diarrhea, body aches, headaches, anosmia, and hyposmia). Approximate …
New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
Patel A, Charani E, Ariyanayagam D, Abdulaal A, Denny SJ, Mughal N, Moore LSP. Patel A, et al. Clin Microbiol Infect. 2020 Sep;26(9):1236-1241. doi: 10.1016/j.cmi.2020.05.026. Epub 2020 Jun 2. Clin Microbiol Infect. 2020. PMID: 32502645 Free PMC article.
RESULTS: Of 386 patients, 141 (92 community patients, 49 discharged inpatients) were included for analysis; 77/141 (55%) reported anosmia and ageusia, nine reported only ageusia and three only anosmia. ...Six household contacts had anosmia only. CONCLUSIONS: …
RESULTS: Of 386 patients, 141 (92 community patients, 49 discharged inpatients) were included for analysis; 77/141 (55%) reported anosmia …
Epidemiology of smell and taste dysfunction.
Doty RL. Doty RL. Handb Clin Neurol. 2019;164:3-13. doi: 10.1016/B978-0-444-63855-7.00001-0. Handb Clin Neurol. 2019. PMID: 31604555 Review.
Moreover, population-based studies have identified, or confirmed observations of case-control and other studies, a wide range of factors that impact the chemical senses. ...
Moreover, population-based studies have identified, or confirmed observations of case-control and other studies, a wide range of fact …
COVID-19, anosmia, and ageusia in atopic children.
Parisi GF, Brindisi G, Indolfi C, Diaferio L, Marchese G, Ghiglioni DG, Zicari AM, Miraglia Del Giudice M. Parisi GF, et al. Pediatr Allergy Immunol. 2022 Jan;33 Suppl 27(Suppl 27):99-101. doi: 10.1111/pai.13644. Pediatr Allergy Immunol. 2022. PMID: 35080301 Free PMC article.
More than a year and a half after the beginning of the coronavirus disease 2019 (COVID-19) pandemic, symptoms, such as loss of smell and taste (anosmia and ageusia, respectively), remain difficult to characterize and quantify, especially in children, since no validated tes …
More than a year and a half after the beginning of the coronavirus disease 2019 (COVID-19) pandemic, symptoms, such as loss of smell and tas …
1,129 results